Research map: Assessing tumor heterogeneity and FLOT/FOLFOX-induced alterations in cancer stem cells and cancer immune checkpoint molecules using patient-derived tumor organoids

Back to the article

Papers in this map

  1. Tumour heterogeneity and resistance to cancer therapies · Ibiayi Dagogo‐Jack · 2017 · 3978 citations · Cited by this paper
  2. Role of β and α1-adrenoceptors in pancreatic regulation of glucose homeostasis, apoptosis, and fibrosis in dexamethasone-treated rats: A new insight into β-arrestin2 crosstalk with cAMP, PKA-ERK1/2-CREB, and PKB-FOXO1 signaling pathways · 2025 · Related
  3. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Florian Lordick · 2022 · 1526 citations · Cited by this paper
  4. Synergistic inhibition of CitH3 and S100A8/A9: A novel therapeutic strategy for mitigating sepsis-induced inflammation and lung injury · 2025 · Related
  5. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy · Yuanjun Lu · 2020 · 508 citations · Cited by this paper
  6. Rapamycin ameliorates inflammatory pain via recovery of autophagy flux mediated by mammalian target of rapamycin (mTOR) signaling pathway in the rat spinal cord · 2025 · Related
  7. MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy · Annelisa M. Cornel · 2020 · 479 citations · Cited by this paper
  8. Attenuation of senile pruritus by PAC-14028-mediated downregulation of the NF-κB and MAPK pathways · 2025 · Related
  9. Regulation of PD-L1 Expression by NF-κB in Cancer · Fabrizio Antonangeli · 2020 · 398 citations · Cited by this paper
  10. Impact of tacrolimus on interferon gamma ELISpot assay results for the assessment of T-cell immunity: Proof-of-concept · 2025 · Related
  11. Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy · Peter Godwin · 2013 · 311 citations · Cited by this paper
  12. FGF19 is a biomarker associated with prognosis and immunity in colorectal cancer · 2025 · Related
  13. Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells · Shan Wan · 2012 · 301 citations · Cited by this paper
  14. High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8 + T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients · 2025 · Related
  15. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade · Shengqing Stan Gu · 2021 · 291 citations · Cited by this paper
  16. Cucurbitacin B inhibits Th17 cell differentiation via the suppression of the JAK/STAT pathway and alleviates collagen-induced arthritis in mice · 2025 · Related
  17. The NF-κB Pathway and Cancer Stem Cells · Amanda L. Rinkenbaugh · 2016 · 262 citations · Cited by this paper
  18. Chemotherapy elevates cell surface PD-L1 and MHC-I expression in apoptotic gastric cancer cells · 2025 · Related
  19. Targeting cancer stem cells to suppress acquired chemotherapy resistance · Samuel J. Vidal · 2013 · 244 citations · Cited by this paper
  20. Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell · Jianpeng Gao · 2018 · 213 citations · Cited by this paper
  21. Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy · Katherine Ismei Zhou · 2020 · 197 citations · Cited by this paper
  22. Patient-derived tumor organoids for prediction of cancer treatment response · Peter W. Nagle · 2018 · 181 citations · Cited by this paper
  23. Chemotherapy and Cancer Stem Cells · Jeremy N. Rich · 2007 · 154 citations · Cited by this paper
  24. Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance · Ebrahim H. Maleki · 2023 · 134 citations · Cited by this paper
  25. Gastric cancer—Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review · Tajul Islam Mamun · 2024 · 124 citations · Cited by this paper
  26. 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells · Zhiyuan Xu · 2015 · 118 citations · Cited by this paper
  27. A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells · Christian Kaltschmidt · 2019 · 105 citations · Cited by this paper
  28. Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours · Stefania Crucitta · 2022 · 98 citations · Cited by this paper
  29. The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis · Cai M. Roberts · 2019 · 77 citations · Cited by this paper
  30. Hypoxia-Inducible Factors Modulate the Stemness and Malignancy of Colon Cancer Cells by Playing Opposite Roles in Canonical Wnt Signaling · Paula Santoyo‐Ramos · 2014 · 76 citations · Cited by this paper
  31. Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy · Tianping Peng · 2025 · 73 citations · Cited by this paper
  32. Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics · Gang Che · 2024 · 72 citations · Cited by this paper
  33. Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer · Arnaud Da Cruz Paula · 2017 · 63 citations · Cited by this paper
  34. HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer · Akio Kaito · 2019 · 63 citations · Cited by this paper
  35. Cancer stem cells: Recent insights and therapies · Hongyu Zhou · 2023 · 60 citations · Cited by this paper
  36. Antimicrobial Peptide TP4 Induces ROS-Mediated Necrosis by Triggering Mitochondrial Dysfunction in Wild-Type and Mutant p53 Glioblastoma Cells · Bor‐Chyuan Su · 2019 · 55 citations · Cited by this paper
  37. Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer · Melissa Javellana · 2021 · 55 citations · Cited by this paper
  38. Chemotherapy‐Enriched THBS2‐Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications · Kai Yu Ng · 2021 · 50 citations · Cited by this paper
  39. Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy · Shijia Kong · 2024 · 44 citations · Cited by this paper

Source: OpenAlex (CC0)